QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
NASDAQ:CERE

Cerevel Therapeutics (CERE) News Today

$20.36
+0.09 (+0.44%)
(As of 10/4/2023 ET)
Compare
Today's Range
$19.59
▼
$20.50
50-Day Range
$20.26
▼
$30.65
52-Week Range
$19.59
▼
$35.98
Volume
587,972 shs
Average Volume
619,369 shs
Market Capitalization
$3.21 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.90
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesShort InterestSocial Media
SourceHeadline
seekingalpha.com logoCeres Power: Business Model Concerns Persist
seekingalpha.com - September 28 at 5:13 PM
nasdaq.com logoPiper Sandler Initiates Coverage of Cerevel Therapeutics Holdings (CERE) with Overweight Recommendation
nasdaq.com - September 28 at 3:53 PM
MarketBeat logoCerevel Therapeutics (NASDAQ:CERE) Earns Overweight Rating from Analysts at Piper Sandler
americanbankingnews.com - September 28 at 4:38 AM
MarketBeat logoCerevel Therapeutics (NASDAQ:CERE) Stock Price Down 3.2%
americanbankingnews.com - September 24 at 4:22 AM
benzinga.com logoParkinson's Disease Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 (Updated)
benzinga.com - September 22 at 7:49 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN), ADC Therapeutics (ADCT) and Sanofi (OtherSNYNF)
markets.businessinsider.com - September 12 at 6:56 AM
marketbeat.com logoBoone Capital Management LLC Takes Position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
marketbeat.com - September 12 at 5:14 AM
benzinga.com logoCannabis Odor Sparks Legal Battle Impacting California Real Estate, Lawsuit Alleges Nuisance
benzinga.com - September 8 at 6:11 PM
marketbeat.com logoCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Director Sells $1,203,500.00 in Stock
marketbeat.com - September 8 at 5:23 PM
marketbeat.com logoFinepoint Capital LP Has $13.16 Million Position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
marketbeat.com - September 3 at 12:13 PM
marketbeat.com logoProfund Advisors LLC Acquires Shares of 39,316 Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
marketbeat.com - September 1 at 7:53 AM
finance.yahoo.com logoCerevel Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
finance.yahoo.com - August 29 at 7:06 AM
marketbeat.com logoCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Given Average Rating of "Moderate Buy" by Analysts
marketbeat.com - August 28 at 2:22 AM
markets.businessinsider.com logoAnalysts Are Bullish on Top Healthcare Stocks: Axsome Therapeutics (AXSM), Catalent (CTLT)
markets.businessinsider.com - August 25 at 8:39 AM
bizjournals.com logoJ&J-backed startup raises $150M in VC for neuroscience drugs
bizjournals.com - August 23 at 8:51 AM
finance.yahoo.com logoInsiders Buy the Dip in These 2 Beaten-Down Stocks, Analysts Say They Could Be Ready to Bounce Back — Here’s Why You Should Pay Attention
finance.yahoo.com - August 11 at 6:03 PM
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Revance Therapeutics (RVNC), Personalis (PSNL)
markets.businessinsider.com - August 9 at 7:56 AM
marketbeat.com logoQ3 2023 EPS Estimates for Cerevel Therapeutics Holdings, Inc. Reduced by HC Wainwright (NASDAQ:CERE)
marketbeat.com - August 9 at 3:25 AM
marketbeat.com logoCerevel Therapeutics (NASDAQ:CERE) PT Lowered to $25.00 at Mizuho
marketbeat.com - August 7 at 8:18 AM
marketbeat.com logoQ3 2023 Earnings Estimate for Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Issued By HC Wainwright
marketbeat.com - August 7 at 5:44 AM
markets.businessinsider.com logoStifel Nicolaus Keeps Their Buy Rating on Cerevel Therapeutics Holdings (CERE)
markets.businessinsider.com - August 6 at 10:30 PM
benzinga.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cerevel Therapeutics Holdings, Inc. - CERE
benzinga.com - August 5 at 12:38 AM
msn.com logoCerevel: Drop On Data Delay For EMPOWER Program Provides Buy Opportunity
msn.com - August 4 at 7:38 PM
marketbeat.com logoCerevel Therapeutics (NASDAQ:CERE) Sets New 12-Month Low Following Analyst Downgrade
marketbeat.com - August 4 at 2:13 PM
markets.businessinsider.com logoAnalysts Are Bullish on Top Healthcare Stocks: Cerevel Therapeutics Holdings (CERE), G1 Therapeutics (GTHX)
markets.businessinsider.com - August 3 at 7:53 AM
msn.com logoWhy Is Cerevel Therapeutics Stock Trading Lower Today?
msn.com - August 3 at 2:52 AM
seekingalpha.com logoCerevel Therapeutics falls on delayed data readouts
seekingalpha.com - August 3 at 2:52 AM
markets.businessinsider.com logoCerevel Therapeutics Holdings (CERE) Receives a Hold from Berenberg Bank
markets.businessinsider.com - August 3 at 2:52 AM
msn.com logoCerevel Therapeutics falls on delayed readout
msn.com - August 3 at 2:52 AM
marketbeat.com logoCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Given Consensus Rating of "Moderate Buy" by Analysts
marketbeat.com - August 3 at 2:48 AM
msn.com logoCerevel Therapeutics GAAP EPS of -$0.63 beats by $0.06
msn.com - August 2 at 11:08 AM
fool.com logoWhy Shares of Cerevel Therapeutics Are Dropping Wednesday
fool.com - August 2 at 11:08 AM
finance.yahoo.com logoCerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
finance.yahoo.com - August 2 at 11:08 AM
marketbeat.com logoSG Americas Securities LLC Purchases 14,849 Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
marketbeat.com - July 31 at 4:41 AM
marketbeat.com logoCerevel Therapeutics (CERE) Set to Announce Earnings on Wednesday
marketbeat.com - July 26 at 4:26 AM
markets.businessinsider.com logoAnalysts Are Bullish on Top Healthcare Stocks: Viridian Therapeutics (VRDN), Arbutus Biopharma (ABUS)
markets.businessinsider.com - July 11 at 8:51 AM
marketbeat.com logoCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Receives Consensus Recommendation of "Moderate Buy" from Analysts
marketbeat.com - July 9 at 2:16 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM) and Ambrx Biopharma (AMAM)
markets.businessinsider.com - July 7 at 3:28 PM
finance.yahoo.com logoCerevel Therapeutics to Report Second Quarter 2023 Financial Results and Business Updates on Wednesday, August 2, 2023
finance.yahoo.com - July 5 at 9:48 AM
markets.businessinsider.com logoAnalysts Conflicted on These Healthcare Names: Calliditas Therapeutics (CALT), Surface Oncology (SURF) and Crinetics Pharmaceuticals (CRNX)
markets.businessinsider.com - June 20 at 7:56 AM
marketbeat.com logoETF Managers Group LLC Makes New Investment in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
marketbeat.com - June 20 at 5:09 AM
finance.yahoo.com logoCerevel Therapeutics Appoints Paul Burgess as Chief Business Development and Strategic Operations Officer
finance.yahoo.com - June 15 at 10:25 AM
marketbeat.com logoCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Given Consensus Rating of "Moderate Buy" by Brokerages
marketbeat.com - June 14 at 2:16 AM
marketbeat.com logoNeuberger Berman Group LLC Invests $2.26 Million in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
marketbeat.com - June 12 at 11:45 AM
marketbeat.com logoAmerican Century Companies Inc. Buys New Stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
marketbeat.com - June 11 at 4:48 AM
marketbeat.com logoVictory Capital Management Inc. Has $257,000 Stock Position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
marketbeat.com - June 8 at 4:51 AM
marketbeat.com logoFirst Trust Advisors LP Sells 32,121 Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
marketbeat.com - June 7 at 5:40 AM
seekingalpha.com logoCerevel: High Priced Stock Doing Interesting Science
seekingalpha.com - June 4 at 6:38 AM
marketbeat.com logoPrincipal Financial Group Inc. Increases Holdings in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
marketbeat.com - June 4 at 4:55 AM
247wallst.com logoGoldman Sachs Maintains Cerevel Therapeutics Neutral Recommendation
247wallst.com - May 24 at 1:41 PM
Get Cerevel Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CERE and its competitors with MarketBeat's FREE daily newsletter.



CERE Media Mentions By Week

CERE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CERE
News Sentiment
▼
-0.27

0.45
▲
Average
Medical
News Sentiment

CERE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CERE Articles
This Week
▼
4

3
▲
CERE Articles
Average Week

Get Cerevel Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CERE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:CERE) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -